Comments
Lincoln Pharmaceuticals Ltd on Monday said its standalone revenues in the first quarter of 2013-14, ended June 30, increased 30 per cent compared to the corresponding quarter last fiscal.
Announcing its unaudited financial results, the revenues were Rs 39.23 crore (Rs 30.22 crore) while PAT stood at Rs 3.50 crore (Rs 1.12 crore).
The company increased its profitability in spite of the pressure of inflation, increase in input cost and financial cost in general economic conditions, according to a statement here.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.